Use of Pancreatic CTCs as a Prognosis Marker for Pancreatic Cancer Progression and Establishment of a CTC-Based Drug-Screening Platform for Chemotherapeutic Regimens (III)

2015-08-012024-05-17https://scholars.lib.ntu.edu.tw/handle/123456789/678748Use of Pancreatic CTCs as a Prognosis Marker for Pancreatic Cancer Progression and Establishment of a CTC-Based Drug-Screening Platform for Chemotherapeutic Regimens (III)